黄金大米风波已持续近半个月，昨日，中国疾病预防控制中心公布了黄金大米的调查进展，中疾控称未参与黄金大米研究，该项目也未提交卫生部审批。中疾控研究员荫士安因卷入此事且说法前后矛盾，已被停职并接受调查。

Golden rice storm has lasted for nearly half a month,yesterday,China's centers for disease control and prevention released golden rice research progress,The CDC says does not participate in the golden rice research,The program also fails to submit the health examination and approval.CDC researcher in the shadow, and because of the involved and inconsistent,Has been suspended and accept investigation.

　　昨日，中疾控表示，针对今年8月1日刊登在《美国临床营养杂志》上的黄金大米试验涉及的问题，已经成立了专门的科学审查委员会，核查相关科研档案，并与论文涉及到的相关单位进行了沟通，收集有关资料，对论文中提及的主要内容进行深入了解和逐一核查。

yesterday,CDC said in,This year in August 1, published in[American journal of clinical nutrition]The gold rice test of the issues involved,Has established the special scientific review committee,Check relevant scientific research files,And the paper involves the related units communication,Collect relevant material,To the main content of the paper mentioned in-depth understanding and each check.

　　中疾控调查称，经审查科研档案，中疾控营养食品所和其他直属单位均没有批准和参与有关“黄金大米”的研究。论文所述的研究内容也没有按规定提交卫生部伦理审查委员会审查和卫生部审批。

For disease control in the survey said,Scientific research files after examination,CDC in nutrition food and other directly under the units are not approved and participate in relevant"Golden rice"research.The paper described the research content of no in accordance with the provisions, present ministry of public health ethics review committee and the ministry of health examination and approval.

　　按照卫生部2007年颁布的涉及人的生物医学研究伦理审查办法规定，人体试验的先决条件是在完成大量临床前研究，证实其安全性、有效性，经食品或药品部门审查批准后，发给临床试验的批准证书，然后经过伦理委员会批准，再经受试者在《知情同意书》上签字同意后，才可以开始人体试验。

According to the ministry of health issued in 2007 in the biomedical research ethics review measures,Human trials of the prerequisite is in complete before a large number of clinical research,Confirmed its safety/effectiveness,The food or pharmaceutical department after examination and approval,Issue the approval certificate of clinical trials,Then after ethics committee approval,Then through the subjects[Informed consent]Agree to sign,Just can begin to human trials.

　　此前，也就是9月5日发表的调查结果中称，卷入此事的中疾控研究员荫士安称该项目是美国与浙江医学科学院的合作项目，且已经过了浙江医学科学院伦理委员会的审查。浙江医学科学院有关负责人曾表示，确实审查过，但该项目并未在审查期限内实施。

after,On September 5, is also published the results of the survey said,Involved in the CDC researcher shadow and Ann says the project is the United States and zhejiang academy of medical sciences cooperation projects,And has been zhejiang academy of medical sciences ethics committee review.Zhejiang academy of medical sciences, officials said,Really review over,But this project was not review period implementation.

　- 相关新闻 - related news

　　海安“黄金米”非“黄金大米” haian"Golden rice"not"Golden rice"

　　海安县农委会称非转基因大米，只是商标名称 HaiAnXian council says not genetically modified rice,Only brand name

　　据《人民日报》报道 日前，有网络传言称，江苏省海安县规模种植转基因大米——“黄金大米”，并指当地一家公司涉嫌提供“黄金大米”给湖南一所小学进行“转基因大米人体试验”。

According to[People's Daily]A report,A network rumors,Jiangsu province HaiAnXian scale planting genetically modified rice --"Golden rice",And refers to a local company provide suspected"Golden rice"To a primary school in hunan"Genetically modified rice human trials".

　　海安县农业委员会称，获知网上传言后，组建了专家组进行审查。经查，海安县现有水稻种植面积55万亩，全部选用常规品种，无转基因品种，未种植转基因“黄金大米”。

HaiAnXian agriculture committee said,Learn online after rumors,Set up expert group for review.The basis of,HaiAnXian existing rice planting area of 550000 mu,All use conventional varieties,No transgenic varieties,Not growing genetically modified"Golden rice".

　　该农委会还证实，南通市百味食品有限公司生产的“黄金米”只是注册商标名称，该产品为有机大米，色泽为白色，不是“黄金大米”。打开“黄金米”包装，呈现的是乳白色大米，并非黄色。

The council also confirmed,Nantong hundred food co., LTD production"Golden rice"Only registered trademark name,This product is organic rice,Color is white,not"Golden rice".open"Golden rice"packaging,Present is milky white rice,Not yellow.

　　对于网上流传的“海安种植黄金大米”一说，南通网负责人郭小平说，是因为该网站编辑不了解“黄金米”和“黄金大米”的区别，从网络上找来图片和资料，加了上去。

For online popular"Haian planting golden rice"said,Nantong network GuoXiaoPing person in charge said,Because the web editor don't understand"Golden rice"and"Golden rice"difference,From the Internet to find pictures and material,added.

　【进展】 [progress]

　　中疾控涉案研究员停职调查 CDC researchers involved in the investigation of suspended

　　调查结果显示，论文第三作者、美国塔夫茨大学汤光文在我国的主要合作者研究员荫士安前后说法不一致，目前，中疾控已停止其工作，责令接受调查。

According to the results of the survey,The paper third author/The United States tufts ShangGuangWen in China's main partners researcher shadow and before and after the Ann does not agree,At present,CDC has stopped in its work,Investigation shall be ordered to accept.

　　此前调查中，荫士安曾表示，在美国的论文发表前，他收到了《美国临床营养学杂志》的论文发表通知，签字同意发表。但同时，他又表示，关于美国塔夫茨大学汤光文负责的项目研究中，是否使用了“黄金大米”，并不知情。这两个说法显然矛盾。

After investigation,Shadow and Ann has said,In the United States before of papers published,He received[The American journal of clinical nutrition]Papers published notice,Sign agreed on.But at the same time,And he said,About the American tufts ShangGuangWen responsible for project study,Whether you used the"Golden rice",Is not familiar with the.The two saying obviously contradiction.

　　中疾控表示，中心科学审查委员会已联系论文责任作者汤光文，要求提供论文所述研究的相关材料和详细实施过程说明；同时要求美国塔夫茨大学对该项目开展调查，并提供详情报告。

CDC said in,Center science review committee has contact the author ShangGuangWen paper responsibility,Required to provide paper described the relevant research materials and detailed implementation procedure specification;At the same time demand that the United States tufts on the project survey,And provide details report.

　　中疾控还称会对该论文进行全面、客观、公正的调查。调查结果将及时向社会公布。新京报记者 蒋彦鑫

The CDC says of the paper will be comprehensive/objective/And impartial investigation.Survey results will be released to the society in time.The Beijing news reporter JiangYanXin